Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On Post author:Sam Post published:November 15, 2017 Post category:BioPharma Teva’s stock jumped as investors get more hopeful about the future. Source: BioSpace You Might Also Like As the IDO Battle Gets Ugly, Bristol-Myers Shows Off Early Data for Combo Trial November 9, 2017 Valeant to Shave an Additional $200M From Its Mountain of Debt January 25, 2018 Shire Snaps Up Rights to a Preclinical Autoimmune Candidate for Undisclosed Sum January 29, 2018
